My next big call (under $1)

Dear Investor,

My track record in crypto speaks for itself:

KDA: 17,556%
PRE: 3,900%
OCEAN: 2,650%
ALBT: 1,933%

Every single one of these was recommended to our community before the big move happened.

It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage.

And its biggest supply cut in history just happened weeks ago.

With Bitcoin down 45% and the market stuck in extreme fear for nearly three weeks straight, this is the exact environment where my biggest winners have been found.

Low prices. High fundamentals. Maximum fear. Institutional accumulation happening in the background.

I've seen this movie before. And I believe this coin could deliver returns that rival—or exceed—any pick I've ever made.

The full report is usually $97. On this page today, it's $3:

Get my #1 coin now… while it's still under $1.

To your massive success,

Bryce Paul
Crypto 101

Bonus Article from MarketBeat Media

CooperCompanies Insiders Buy as Rebound Setup Forms

Authored by Thomas Hughes. Date Posted: 3/9/2026.

Key Points

CooperCompanies insiders bought shares in late 2025, highlighting a value opportunity that has reemerged in early 2026.
Analysts and institutions are accumulating this stock, and have its price set up to reverse course as the year progresses.
Capital returns, specifically share buybacks, provide leverage and increase value for investors, underpinning a robust outlook for a stock price rebound.
Special Report: Why I'm avoiding Nvidia (and buying these 3 AI stocks instead) (From TradingTips)

CooperCompanies (NASDAQ: COO) insiders signaled confidence in the company's growth outlook by buying shares in December, extending a trend that began the month before. Insiders — including the CEO, several directors and other C-suite executives — bought shares at long-term lows, helping catalyze a rebound, but the story isn't finished.

COO pulled back in early March after an otherwise healthy earnings report, offering another entry opportunity. Headwinds remain, but the long-term outlook is bullish, supported by growth, improving profitability and sustained capital returns.

Elon built the impossible in 19 days. This $3B company made it happen. (Ad)

Louis Navellier put the paid version of ChatGPT head-to-head against the FREE version of Elon's Grok, and it wasn't even close—Grok produced dozens of picture-perfect results while ChatGPT struggled to conjure even one. In just 19 days, Elon built a system that Oracle executives said was impossible by connecting 200,000 GPUs in a 114-acre facility, creating what Nvidia's CEO calls superhuman AI, and one tiny company's technology 49 times smaller than Tesla was central to the entire feat.

Watch the live demo and get the ticker now

CooperCompanies is a leading consumer-focused medical device company organized around two main segments: vision and women's/family health. The vision segment is best known for contact lenses that are consistently ranked among the top three globally. The women's health division is a major player in contraception, fertility and gynecology. Long-term forecasts suggest a mid-single-digit revenue growth pace through the middle of the next decade, with earnings expected to grow slightly faster.

Capital Returns Keep Analysts and Institutions Interested in COO Stock

CooperCompanies' capital-return program is entirely share repurchases. The buybacks have been sizable and consistent, enhancing shareholder value. Fiscal Q1 2026 repurchase activity, combined with prior-quarter buybacks, resulted in nearly a 2.25% year-over-year reduction in shares outstanding, and the repurchase pace is expected to continue in coming quarters.

The balance sheet raises few concerns and supports the investment case. Quarter-ending highlights include increased cash and assets, reduced debt and liabilities, and higher equity despite aggressive repurchases. Equity rose about 1.5%, and leverage is very low, suggesting the company can continue executing its strategy of expanding product lines and pursuing targeted acquisitions. CooperCompanies has a history of selectively acquiring niche, high-quality products that complement its core segments.

Analysts' coverage reflects confidence in the business, assigning a Moderate Buy rating. While one Sell rating is on file, the consensus skews bullish — roughly 50% Buy and 49% Hold — with coverage increasing on a trailing-12-month basis and the price target firming after the March earnings update. Consensus implies about 25% upside from early March lows; a move toward the roughly $90 consensus target would establish a new long-term high, break key resistance and complete a broader market reversal.

Technical Reversal Is in Play: Head-and-Shoulders Pattern Forming

Price action in COO stock, combined with solid fundamentals, suggests a head-and-shoulders reversal may be forming. The first shoulder emerged in early 2025, the head developed mid-year, and the second shoulder now appears to be taking shape. There is a risk of further weakness—potentially testing support around $70 or $65—but that outcome looks less likely given the company's cash flow and capital-return profile.

Institutional trends add to the case for a reversal. Institutional ownership remains relatively light at about 25%, but institutions have been accumulating shares and activity is ramping up. Selling has increased as well, though at a slower pace, which may keep volatility elevated until another catalyst appears. One potential catalyst is the conclusion of the strategic review that began last year; finalizing that review should help restore investor confidence.

CooperCompanies Retreats After Solid Report

CooperCompanies reported a solid Q1, with both revenue and adjusted earnings beating consensus. A modest gross-margin contraction—partly attributed to tariffs—was offset by operational discipline, leading to overall margin expansion. Adjusted EPS grew close to 20% for the quarter and is likely to continue outpacing estimates as the year progresses. Guidance was nudged higher versus the prior guide but remains conservative. Momentum from newer products such as MyDay and MiSight, which are designed to slow the progression of myopia in children, underpins the company's outlook.

© 2026 Boardwalk Flock LLC. All Rights Reserved.
2382 Camino Vida Roble, Suite I
Carlsbad, CA 92011, United States

The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where appropriate.

Readers acknowledge that the authors are not engaging in the rendering of legal, financial, medical, or professional advice. The reader agrees that under no circumstances Boardwalk Flock, LLC is responsible for any losses, direct or indirect, which are incurred as a result of the use of the information contained within this, including, but not limited to, errors, omissions, or inaccuracies.

Results may not be typical and may vary from person to person. Making money trading digital currencies takes time and hard work. There are inherent risks involved with investing, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk.